☆ 4.8 Article

Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases

FRONTIERS IN IMMUNOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Hematology

Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients

Nora Liebers et al.

BLOOD (2022)

Add to Collection

Article Hematology

Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination

Yair Herishanu et al.

Summary: Patients with chronic lymphocytic leukemia (CLL) have impaired antibody response to COVID-19 vaccination. A third dose of the vaccine can improve the antibody response in some CLL patients. Patients on active treatment and those recently treated with anti-CD20 therapy have lower antibody response rates.

BLOOD (2022)

Add to Collection

Article Hematology

Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy

Stephen Booth et al.

Summary: Patients with active haematological cancer infected with SARS-CoV-2 have a higher risk of mortality, especially patients with acute leukemia and myeloma. Factors such as poor disease control and receiving second or beyond line of treatment are associated with increased mortality risk.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Add to Collection

Article Oncology

Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies

Christina Y. Lee et al.

Summary: Persistent COVID-19 infection is more likely to occur in patients with hematologic malignancies, particularly B-cell lymphomas. Active therapy and diminished T-cell counts are associated with acute mortality, while B cell-depleting therapy is the main cause of rehospitalization. Patients with persistent infection show high viral entropy, especially those with impaired CD8(+) T-cell immunity. These findings highlight the need for additional therapeutic strategies to clear the virus in immunocompromised patients.

CANCER DISCOVERY (2022)

Add to Collection

Article Immunology

High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease

Catherine A. Hogan et al.

Summary: This study examined the presence of SARS-CoV-2 RNA in plasma of COVID-19 patients and found an association between RNAemia and clinical severity. A high proportion of RNAemia was detected, with all deaths occurring in patients with detectable RNAemia.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient

Ji Hoon Baang et al.

Summary: This case illustrates challenges in managing immunocompromised hosts with chronic COVID-19, who may act as persistent shedders and sources of transmission. The patient's lack of seroconversion and prolonged course highlight the importance of humoral immunity in resolving viral infections.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Review Infectious Diseases

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

Cathrine Axfors et al.

Summary: This study assessed the benefits of convalescent plasma treatment compared to placebo or no treatment in COVID-19 patients and found that convalescent plasma treatment did not reduce all-cause mortality. The researchers recommend that convalescent plasma treatment for COVID-19 patients should not be used outside of randomized trials. Collaboration among trial investigators can inform both evidence generation and evidence application in patient care.

BMC INFECTIOUS DISEASES (2021)

Add to Collection

Article Infectious Diseases

SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study

Luna Colagrossi et al.

Summary: This proof-of-concept study of 41 SARS-CoV-2-positive adult individuals revealed that patients with viremia had a higher mortality rate, were more frequently affected by haematological malignancies, and had higher viral loads in respiratory samples. This highlights the importance of early identification of high-risk patients for severe COVID-19, particularly among haematologic patients.

BMC INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Jason D. Goldman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Oncology

Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma

Hajime Yasuda et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)

Add to Collection

Article Oncology

Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?

Roch Houot et al.

EUROPEAN JOURNAL OF CANCER (2020)

Add to Collection

Article Hematology

Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma

Ayse Karatas et al.

TRANSFUSION AND APHERESIS SCIENCE (2020)

Add to Collection

Review Hematology

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

Abi Vijenthira et al.

BLOOD (2020)

Add to Collection

Letter Medicine, General & Internal

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

Bina Choi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Letter Medicine, General & Internal

Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer

Teresa Aydillo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Critical Care Medicine

Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

Jesus F. Bermejo-Martin et al.

CRITICAL CARE (2020)

Add to Collection

Article Medicine, General & Internal

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial

Gilles Salles et al.

LANCET (2011)

Add to Collection

Letter Medicine, General & Internal

Treatment with convalescent plasma for influenza A (H5N1) infection

Boping Zhou et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.